Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Ceribell Inc (CBLL)

Ceribell Inc (CBLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates GlobeNewswire - Mon Nov 24, 7:00AM CST

SUNNYVALE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 19.15 (+6.39%)
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference GlobeNewswire - Wed Nov 19, 3:05PM CST

SUNNYVALE, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 19.15 (+6.39%)
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum GlobeNewswire - Thu Nov 6, 3:05PM CST

SUNNYVALE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 19.15 (+6.39%)
Ceribell Reports Third Quarter 2025 Financial Results GlobeNewswire - Tue Nov 4, 3:05PM CST

SUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 19.15 (+6.39%)
Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025 GlobeNewswire - Tue Oct 21, 3:05PM CDT

SUNNYVALE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 19.15 (+6.39%)
William Blair Keeps Their Buy Rating on Ceribell, Inc. (CBLL) Tipranks - Wed Oct 15, 2:58PM CDT

William Blair analyst Brandon Vazquez maintained a Buy rating on Ceribell, Inc. today. The company’s shares opened today at $11.90.Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

CBLL : 19.15 (+6.39%)
Medtech Leader Erica Rogers Joins Ceribell Board of Directors GlobeNewswire - Mon Sep 22, 7:00AM CDT

SUNNYVALE, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell” or the “Company”), a medical technology company focused on transforming the diagnosis and management...

CBLL : 19.15 (+6.39%)
Ceribell Reports Second Quarter 2025 Financial Results GlobeNewswire - Tue Aug 5, 3:05PM CDT

SUNNYVALE, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 19.15 (+6.39%)
Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference GlobeNewswire - Tue Jul 29, 3:05PM CDT

SUNNYVALE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 19.15 (+6.39%)
Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025 GlobeNewswire - Tue Jul 22, 3:05PM CDT

SUNNYVALE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 19.15 (+6.39%)

Barchart Exclusives

Michael Burry Doubles Down on Molina Healthcare Stock. What Is the Bull Case for MOH Here? Barchart - 27 minutes ago
Burry finds value in holding this healthcare counter for the long term. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot